I have the honor of delivering the 2022 State of the Department Address during Grand Rounds next month. I hope you will join me in person for the event on December 15 in Medical Alumni Auditorium. We have already begun to assemble the data that tells the story of this past year, and I am grateful to our department’s administrative team for their thoroughness and responsiveness to queries. The continuity these professionals provide helps us look not just at the last year, but the last decades in some cases, to identify trends and insights into future directions for the department. One area we have been looking at is how our department has been performing in the research mission. There are multiple prisms through which we can examine our work in research, beyond the bottom line of new grant awards, the narrow focus of a Blue Ridge ranking, or the number of publications in high-impact, peer-reviewed journals. These are all valuable measures and serve a purpose when comparing our department to other institutions. But they are not always accurate indicators of what we value, what makes the soil, so to speak, so rich for an Iowa researcher looking to grow a career.
Research also coincides with clinical care and a recent example of the successful blending of the two can be seen in the designation of our polycystic kidney disease clinic as a Center of Excellence in Autosomal Dominant PKD by the PKD Foundation. It has taken nearly a decade of close teamwork from many to build the clinic and the research that feeds it into one worthy of this prestigious designation. And evidence of that research into this common genetic disease can be seen in a recent publication in the Journal of the American Society of Nephrology (JASN) from Nephrology Division Director Dr. Chou-Long Huang and his lab. That JASN publication, which revealed new insights into the pathogenesis of ADPKD and thus new avenues for treatment, drew plenty of attention including an editorial comment because of its ground-breaking discovery into a condition with limited therapeutic options. It is impressive work that takes many people working closely across all disciplines, which is, fortunately, something we are very good at here in Iowa.
